THE DIFFERENCE IS IN THE DATA™
With strong science, robust processes, and a sense of urgency, MMS is redefining the CRO experience. Gain new insights from our data-focused and tech-enabled team of experts. Explore our services:
Regulatory Affairs
& Operations
Data Management
& Biostatistics
Regulatory &
Medical Writing
Drug Safety &
Pharmacovigilance
Quality & Compliance
Services
Transparency
Services
Helping sponsors navigate a complex regulatory environment
MMS is an award-winning, data-focused clinical research organization (CRO) that supports the pharmaceutical, biotech, and medical device industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience and a data-driven approach to drug development make MMS a valuable CRO partner, creating compelling submissions that meet rigorous regulatory standards.
Industry experts across 4 continents are available to support your programs 24×7 with a 97 percent sponsor satisfaction rating
Latest News
MAPS has submitted an NDA to the FDA for the first PTSD psychedelic therapy with MMS support.
MAPS PBC selected MMS as its CRO partner for the development of NDA for MDMA-assisted therapy for PTSD. If approved, MDMA-assisted therapy could be the first psychedelic-assisted therapy.
Latest Webinar
View To Our Latest Webinar on Training That Transforms: A Quality Approach
In an era where knowledge is power, the ability to effectively train and develop your team sets the leaders apart from the followers. “Training That Transforms: A Quality Approach” is more than a webinar; it’s a stepping stone to excellence in your educational initiatives.
Featured Blog
The Silent Battle: Exploring PTSD Treatments and Psychedelic Research in Veteran Care
Explore PTSD treatments, psychedelic research, and MMS’ role in veteran care. Gain insights from combat medic Ritchie Patton, MMS’ regulatory expert. Connect for deeper insights.
Featured Sponsor
MMS Partners with I-ACT to Advance Children’s Clinical Trials
MMS collaborates with I-ACT to accelerate pediatric clinical trials, supporting life-saving therapies for children. Learn more about the Spin Challenge and our commitment to advancing pediatric drug development.